Charles River Laboratories International, Inc. (NYSE: CRL) Securities Fraud Class Action

Charles River Laboratories International, Inc. (NYSE: CRL) Securities Fraud Class Action

CompanyCharles River Laboratories International, Inc.
CourtUnited States District Court for the District of Massachusetts
Case Number23-cv-11132
JudgeHonorable Denise J. Casper
Class PeriodNovember 30, 2022 through March 15, 2023
Security TypeSecurities

Case Background:
This is a federal securities fraud class action lawsuit on behalf of those who purchased or otherwise acquired Charles River Laboratories International, Inc. (“Charles River”) (NYSE: CRL) securities between November 30, 2022 and March 15, 2023, inclusive (the “Class Period”).

On February 22, 2023, Charles River revealed that the company had received a subpoena from the U.S. Department of Justice relating to an ongoing investigation in conjunction with the U.S. Fish and Wildlife Service into the supply chain and illegal importation of non-human primates for research. On the same day, during an earnings call with investors, James C. Foster, the company’s CEO, stated that the “investigation in current [non-human primate] supply situation will result in study delays in our Safety Assessment business.” He further stated that the investigation into the Cambodian non-human primate chain would reduce the annual revenue forecast by approximately 200 basis points to 400 basis points.

Current Status of Case:
On October 16, 2025, Plaintiffs filed a Motion to Appoint the Substitute Lead Plaintiff. This action is ongoing.

If you wish to discuss this action or have any questions, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at [email protected]. If you would like additional information about the suit, please click on the link “Submit Your Information” above and fill out the form as promptly as possible.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs’ Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent.  

Complete this form with your transactions in Charles River Laboratories International, Inc. between November 30, 2022 through March 15, 2023.

Click here to print a PDF of this form

    Submit Your Information
    SUBMIT YOUR INFORMATION
    * Denotes required field
    Phone Country code
    Purchase Information
    Sales Information
    Did you purchase shares of Charles River Laboratories International, Inc. prior to the Class Period?
    Are you a current or former employee of Charles River Laboratories International, Inc.?
    The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. READ MORE
    I agree to the KTMC disclaimer
    I would like to receive new case alerts by email
    Scroll to Top